Chrome 2001
.
Aetna Intelihealth InteliHealth Aetna Intelihealth Aetna Intelihealth
 
.
. .

   Advertisement
Carepass Ad Carepass Ad .
Chrome 2001
Chrome 2001
Health News Health News
.
Health Highlights: Jan. 24, 2014
January 24, 2014

 

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Artificial Pancreas Could Replace Insulin Injections: Scientists

Human tests of an artificial pancreas are set to begin in 2016 and the first implants could take place within a decade, according to British scientists.

They said the wristwatch-sized device is surgically implanted in the abdomen and releases insulin into the bloodstream, and could make insulin injections a thing of the past for people with diabetes, Britain's Daily Mail reported.

The insulin supply in the first-of-a-kind implant is controlled by a gel barrier. When a user's blood sugar levels rise, the gel liquefies and releases the insulin. When sugar levels drop, the gel hardens again. Insulin is added to the device's reservoir every two weeks.

The device is the next best thing to a cure for diabetes because patients no longer have to manage the condition themselves, according to the development team at De Montfort University in Leicester.

"The device will not only remove the need to manually inject insulin, but will also ensure that perfect doses are administrated each and every time," said Joan Taylor, professor of pharmacy, the Daily Mail reported. "By controlling blood glucose so effectively, we should be able to help reduce related health problems."

The researchers said the implant could help all people with type 1 diabetes and those with type 2 diabetes who require insulin injections.

"This device is cheap and simple to use," Taylor said. "It has the potential to bring an end to the misery of daily injections for diabetics."

-----

Less Educational Content in Kids' Screen Time as They Age

As children get older, their use of educational resources on television and other electronic devices decreases, according to a new study.

Researchers surveyed nearly 1,600 parents and found that what might be considered educational material accounted for less than half of the screen time among youngsters ages 2 to 10. Most of that screen time involved television, The New York Times reported.

The poll also revealed that while children's screen time increases as they get older, there is a decrease in the amount of educational content, according to the researchers at the nonprofit Joan Ganz Cooney Center, a research institute affiliated with the Sesame Workshop.

The survey found that 2- to 4-year-olds had just over two hours a day of screen time, including one hour and 16 minutes of educational content, while children ages 8-10 had more than two and a half hours a day of screen time, but only 42 minutes of that was regarded as educational, The Times reported.

Family income appeared to have an effect. Children in households earning less than $25,000 spent 57 percent of their screen time on educational activities, compared with 38 percent of children in families earning $50,000 to $99,000.

------

Weight May Reduce Effectiveness of Morning-After Pills

European health officials are reviewing morning-after emergency contraceptives to determine if they're less effective in overweight women.

The European Medicines Agency said Friday that it would evaluate new data suggesting that the effectiveness of morning-after pills could be reduced in heavier women. There is no timeline on when the review will be completed, the Associated Press reported.

"We need to find out what the association is with (body mass index) and if there is a cut-off threshold for when the medicine becomes less effective," agency spokeswoman Monika Benstetter said.

The U.S. Food and Drug Administration said late last year that it was studying the issue.

In November, HRA Pharma of France revealed that its morning-after pill Norvelo was less effective in women who weighed more than 165 pounds and did not work in women who weighed more than 176 pounds. The company changed its labels to warn patients, the AP reported.

Norvelo contains the same active ingredient -- levonorgestrel -- as other emergency contraceptives such as ellaOne, Levonnelle and Levodonna.


...

InteliHealth
.
.
.
.
.
More News
InteliHealth .
.
General Health News
Today's News
Today In Health History
This Week In Health
Addiction News
Allergy News
Alzheimer's News
Arthritis News
Asthma News
Babies News
Breast Cancer News
Bronchitis News
Cancer News
Cervical Cancer News
Children's Health News
Cholesterol News
Dental/Oral Health News
Depression News
Diabetes News
Ear, Nose And Throat News
Environmental Health News
Eye News
Fitness News
Genetics News
Headache News
Health Policy News
Heart Attack News
Heart Failure News
Heart Health News
HIV/AIDS News
Infectious Diseases News
Influenza News
Lung Cancer News
Medication News
Men's Health News
Mental Health News
Multiple Sclerosis News
Nutrition News
Parkinson's News
Pregnancy News
Prostate Cancer News
Schizophrenia
Senior Health News
Sexual/Reproductive Health News
Sexual dysfunction
Sleep News
STDs News
Stroke News
Tobacco Cessation News
Weight Management News
Women's Health News
.
.
.
.
InteliHealth
    Print Printer-friendly format    
   
.  
This website is certified by Health On the Net Foundation. Click to verify.
.